bioRxivCell Biology
TP promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
T. Sun, Q. Zhang, Y. Qin, J. Zhao, Y. Tang, X. Hu, W.-l. Zhong, M. Li, S. Zong, M. Li, H. Tao, Z. Zhang, S. Chen, H.-j. Liu, L. Yang, H. Zhou, Y.-r. Liu, C. Yang
Abstract
Tumor progression is dependent on metabolic reprogramming. Metastasis and vasculogenic mimicry (VM) are typical tumor progression. The relationship of metastasis, VM and metabolic reprogramming is not clear. In this study, we identified the novel role of Twist1, a VM regulator, in the transcriptional regulation of the expression of thymidine phosphorylase (TP). We demonstrated that TP promoted extracellular thymidine metabolization into ATP and amino acids through pentose Warburg effect by coupling the pentose phosphate pathway and glycolysis. Moreover, Twist1 relied on TP-induced metabolic reprogramming to promote hepatocellular carcinoma (HCC) metastasis and VM formation mediated by VE-Cad, VEGFR1, and VEGFR2 in vitro and in vivo. TP inhibitor tipiracil reduced promotion effect of TP enzyme activity on HCC VM formation and metastasis. Our findings demonstrate that TP, transcriptionally activated by Twist1, promotes HCC VM formation and metastasis through pentose Warburg effect, contributing to tumor progression.
- organism: human
- assay: metabolomics
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- BACH1 promotes hepatocellular carcinoma progression by targeting PDP1 towards the PI3K-AKT-mTOR signaling activation
Qiqi Bu, Xiaojing Qi, … Yiguo Zhang·Bioorganic ChemistryPeer-reviewed·Oct 31, 2025
- Hepatic stellate cells drive hypoxia-inducible factor (HIF)-dependent metabolic rewiring and proliferation in hepatocellular carcinoma cells
Demi J. Rijlaarsdam, Jung‐Chin Chang, … Celia R. Berkers·bioRxiv·Oct 28, 2026
- PPAR-delta acts as a metabolic master checkpoint for metastasis in pancreatic cancer
B. Parejo-Alonso, D. Barneda, … P. Sancho·bioRxiv·Nov 15, 2021
- Ribosomal protein L23 drives the metastasis of hepatocellular carcinoma via upregulating MMP9
- SLC13A2-transported citrate is a metabolic signal for PKM2 acetylation and degradation to suppress tumor growth
Mengyao Qin, Li Shi, … Jing Xiong·Science AdvancesPeer-reviewed·Apr 8, 2026
- NOTCH1 drives tumor plasticity and metastasis in hepatocellular carcinoma
Katherine E. Lindblad, Romain Donné, … Amaia Lujambio·bioRxiv·Oct 23, 2024